BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35432168)

  • 21. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
    Malzkorn B; Reifenberger G
    Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
    Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative
    Unterrainer M; Fleischmann DF; Vettermann F; Ruf V; Kaiser L; Nelwan D; Lindner S; Brendel M; Wenter V; Stöcklein S; Herms J; Milenkovic VM; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1368-1380. PubMed ID: 31486876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
    Muragaki Y; Chernov M; Maruyama T; Ochiai T; Taira T; Kubo O; Nakamura R; Iseki H; Hori T; Takakura K
    Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC; Lo CM; Wang SH; Su EC
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients.
    Mader MM; Rotermund R; Martens T; Westphal M; Matschke J; Abboud T
    J Neurooncol; 2019 Jan; 141(1):183-194. PubMed ID: 30390175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients.
    Eigenbrod S; Trabold R; Brucker D; Erös C; Egensperger R; La Fougere C; Göbel W; Rühm A; Kretzschmar HA; Tonn JC; Herms J; Giese A; Kreth FW
    Acta Neurochir (Wien); 2014 Aug; 156(8):1427-40. PubMed ID: 24792966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of Tumor Pathology with Fluorescein Uptake and MRI Contrast-Enhancement in Stereotactic Biopsies.
    Xu R; Rösler J; Teich W; Radke J; Früh A; Scherschinski L; Onken J; Vajkoczy P; Misch M; Faust K
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
    Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.
    Schebesch KM; Brawanski A; Doenitz C; Rosengarth K; Proescholdt M; Riemenschneider MJ; Grosse J; Hellwig D; Höhne J
    Clin Neurol Neurosurg; 2018 Sep; 172():177-182. PubMed ID: 30032095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas.
    Ruiz MF; Gennaro MV; Bastone LC; Godoy AR; Torruella M; Perez GR
    Mol Clin Oncol; 2021 Aug; 15(2):150. PubMed ID: 34141429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors.
    Pirotte BJ; Lubansu A; Massager N; Wikler D; Goldman S; Levivier M
    J Neurosurg; 2007 Nov; 107(5 Suppl):392-9. PubMed ID: 18459902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients.
    Su C; Xu S; Lin D; He H; Chen Z; Damen FC; Ke C; Lv X; Cai K
    Eur Radiol; 2022 Jan; 32(1):101-111. PubMed ID: 34272981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI and CT Identify Isocitrate Dehydrogenase
    Patel SH; Batchala PP; Mrachek EKS; Lopes MS; Schiff D; Fadul CE; Patrie JT; Jain R; Druzgal TJ; Williams ES
    Radiology; 2020 Jan; 294(1):160-167. PubMed ID: 31714193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infratentorial Stereotactic Biopsy of Brainstem and Cerebellar Lesions.
    Furtak J; Śledzińska P; Bebyn MG; Szylberg T; Krajewski S; Birski M; Harat M
    Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.